Group B Streptococcus Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Trial to Evaluate the Safety, Tolerability, and Immunogenicity of A Hexavalent Group B Streptococcus Vaccine When Administered Concomitantly With Tdap in Healthy Nonpregnant Women
Condition: Group B Streptococcus Infections Interventions: Biological: Hexavalent Group B streptococcus vaccine; Biological: Tetanus, diphtheria, and acellular pertussis vaccine; Biological: Placebo Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2021 Category: Research Source Type: clinical trials
